Combined cyclophosphamide, vincristine, procarbazine, and prednisone (copp) therapy of malignant lymphoma.Evaluation of 190 patients
- 1 October 1975
- Vol. 36 (4) , 1241-1249
- https://doi.org/10.1002/1097-0142(197510)36:4<1241::aid-cncr2820360409>3.0.co;2-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patientsCancer, 1973
- Non-hodgkin's lymphomas iv. clinicopathologic correlation in 405 casesCancer, 1973
- Chemotherapy of Hodgkin's DiseaseArchives of internal medicine (1960), 1973
- Non-Hodgkin's lymphomas. II. Single agent chemotherapyCancer, 1972
- Combined cyclophosphamide, vincristine, and prednisone therapy of malignant lymphomaCancer, 1971
- Cyclic chemotherapy in lymphomaCancer, 1971
- Combination Chemotherapy in the Treatment of Advanced Hodgkin's DiseaseAnnals of Internal Medicine, 1970
- clinical experience with procarbazine in Hodgkin's disease, reticulum cell sarcoma, and lymphosarcomaCancer, 1970
- Combination Chemotherapy in Generalized Hodgkin's DiseaseBMJ, 1970
- Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcomaCancer, 1970